Celltrion
068270.KS
HK$1,012
Share price
0.17%
Change (1 day)
-10.10%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Cash on Hand
Cash on Hand as of December 2024 : HK$6.11 Billion
According to Celltrion
's latest financial reports the company has HK$6.11 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Celltrion - Cash on Hand chart (from 2007 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | HK$6.04 B | 32.23% |
| 2023-12-31 | HK$4.57 B | 24.16% |
| 2022-12-31 | HK$3.68 B | -53.92% |
| 2021-12-31 | HK$7.99 B | 60.43% |
| 2020-12-31 | HK$4.98 B | 17.84% |
| 2019-12-31 | HK$4.22 B | 13.26% |
| 2018-12-31 | HK$3.73 B | -8.7% |
| 2017-12-31 | HK$4.08 B | 131.83% |
| 2016-12-31 | HK$1.76 B | 71.54% |
| 2015-12-31 | HK$1.02 B | 22.52% |
| 2014-12-31 | HK$0.83 B | 0.85% |
| 2013-12-31 | HK$0.83 B | 8.02% |
| 2012-12-31 | HK$0.77 B | 96.1% |
| 2011-12-31 | HK$0.39 B | -53.74% |
| 2010-12-31 | HK$0.84 B | 473.63% |
| 2009-12-31 | HK$0.14 B | 467.62% |
| 2008-12-31 | HK$26.08 M | -26.6% |
| 2007-12-31 | HK$35.53 M |